FDA official logo
GSRS logoPFDA official logo

SONEFPEGLUTIDE

UNII:J28M3X94LD
Type:INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:SONEFPEGLUTIDE
GSRS Full Record:
J28M3X94LD
i

  • 2854391-99-2
  • 2-33-Glucagon-like peptide II [2-[N-[2-(1H-imidazol-4-yl)acetyl]glycine],30-L-arginine,33a-[N<sup>6</sup>-(3-hydroxypropyl)-L-lysine]] (human), 33a-ether with α-hydro-ω-hydroxypoly(oxy-1,2-ethanediyl), (33a→1) ether with immunoglobulin G4 [1-[1-(3-hydroxypropyl)-L-proline]] (human Fc fragment) (3→3′)-disulfide with immunoglobulin G4 (human Fc fragment)
  • N<sup>1.1</sup>-(3-{α-[3-({[Ala<sup>2</sup>>N-[(1H-imidazol-4-yl)acetyl]Gly1,Lys<sup>30</sup>>Arg<sup>29</sup>]glucagon like peptide 2 (2-33)-peptidyl (1-32)-L-lysine (33)}-N<sup>6.33</sup>-yl)propyl]poly(oxyethylene(3.4 kDa))-ω-oxy}propyl)[immunoglobulin G4 heavy chain constant region C-terminal 221-peptide dimer (3-3')-disulfide], non-glycosylated, immunoglobulin fragment dimer produced in Escherichia coli glucagon-like peptide 2 (GLP-2) receptor agonist
  • Sonefpeglutide
  • glucagon-like peptide 2 (GLP-2) analogue, conjugated through a 3.4 kDa polyethylene glycol (PEG) linker (n ~ 75) to an Fc portion dimer of human immunoglobulin G4 (IgG4)
  • sonefpeglutide [INN]




UNII - J28M3X94LD | UNII Search Service